BMAC injection

BIOLOGICAL2 trials

Sponsors

Harvest Technologies, OhioHealth

Conditions

Critical Limb IschemiaKnee Osteoarthritis

Phase 2

Investigation of Mesenchymal Stem Cell Therapy for the Treatment of Osteoarthritis of the Knee

CompletedNCT02958267

OhioHealthKnee Osteoarthritis

Start: 2016-12-31End: 2018-08-31Updated: 2019-09-24

Phase 3

Bone Marrow Aspirate Concentrate (BMAC) for Treatment of Critical Limb Ischemia (CLI)

CompletedNCT01245335

Harvest TechnologiesCritical Limb Ischemia

Start: 2011-05-31End: 2015-11-30Updated: 2015-12-15

Related Papers

A Single-Blinded Randomized Controlled Trial of Mesenchymal Stem Cell Therapy for the Treatment of Osteoarthritis of the Knee with Active Control

Journal of Stem Cells and Regenerative Medicine2021-05-3121 citations